Valacyclovir in the treatment of genital herpes and herpes zoster

Expert Opinion on Pharmacotherapy

Volumn 3, Issue 1, 2002, Pages 51-58

  Baker, David A ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Antiviral; Genital herpes; Herpes zoster; Shingles; Valacyclovir

Indexed keywords

ACICLOVIR; ANTACID AGENT; ANTIVIRUS AGENT; CIMETIDINE; DIGOXIN; DRUG METABOLITE; FAMCICLOVIR; GUANOSINE DERIVATIVE; NUCLEOSIDE DERIVATIVE; PENCICLOVIR; PLACEBO; PROBENECID; THIAZIDE DIURETIC AGENT; VALACICLOVIR;

ABDOMINAL PAIN; ANTIVIRAL ACTIVITY; ARTHRALGIA; CONTROLLED STUDY; DEPRESSION; DISTRIBUTION VOLUME; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG RESISTANCE; DRUG SAFETY; DRUG TOLERABILITY; DYSMENORRHEA; GENITAL HERPES; HEADACHE; HERPES ZOSTER; HUMAN; NAUSEA; POSTHERPETIC NEURALGIA; REVIEW; VERTIGO; VOMITING;

ACYCLOVIR; ANTIVIRAL AGENTS; CLINICAL TRIALS; HEADACHE; HERPES GENITALIS; HERPES ZOSTER; HUMANS; NAUSEA; RECURRENCE; TISSUE DISTRIBUTION; TREATMENT OUTCOME; VALINE;

EID: 0036310594     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.3.1.51     Document Type: Review

References (22)

1. Antimicrobial agents
2. Improving the care of patients with genital herpes
3. Pharmacology of new antiherpes agents: Famciclovir and valacyclovir
4. Safety and efficacy issues of herpesvirus drugs
5. Famciclovir for treatment of herpesvirus infections
6. Valaciclovir: A review of its long-term utility in the management of genital herpes simplex virus and cytomegalovirus infections
7. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection
8. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis
9. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections
10. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: A randomised, double-blind clinical trial
11. Efficacy, safety and equivalence of 1000 mg once daily and 500 mg twice daily valaciclovir in recurrent genital herpes
12. A comparison of oral valaciclovir 500 mg twice daily for three or five days in the treatment of recurrent genital herpes
13. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: A large-scale dose range-finding study
14. Once-daily valacyclovir hydrochloride for suppression of recurrent genital herpes
15. Once-daily valaciclovir sustains the suppressive efficacy and safety record of acyclovir recurrent genital herpes
16. Valaciclovir for prevention of recurrent herpes simplex virus infection in HIV-infected individuals - A double-blind controlled trial
17. Risk factors for the sexual transmission of genital herpes
18. Suppression of subclinical shedding of herpes simplex virus Type 2 in the genital tract with valacyclovir
19. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults
20. Antiviral therapy for herpes zoster: Randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older
21. Recurrence and resistance patterns of herpes simplex virus following cessation of at least 6 years of chronic suppression with acyclovir
22. A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection